CAM
ABBV icon

Clarity Asset Management’s AbbVie ABBV Stock Holding History

Clarity Asset Management’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-145
Closed -$31.6K – 68
2026
Q1 		$31.6K Sell
145
-5
-3% -$1.11K 0.02% 145
2025
Q4 		$34.3K Buy
150
+1
+0.7% +$228 0.02% 117
2025
Q3 		$34.5K Sell
149
-109
-42% -$22.2K 0.02% 113
2025
Q2 		$47.9K Buy
258
+104
+68% +$19.3K 0.03% 98
2025
Q1 		$32.4K Sell
154
-84
-35% -$16.3K 0.02% 103
2024
Q4 		$42.3K Sell
238
-6
-2% -$1.1K 0.03% 101
2024
Q3 		$48.1K Hold
244
– – 0.03% 78
2024
Q2 		$41.8K Buy
244
+17
+7% +$2.82K 0.03% 90
2024
Q1 		$41.4K Sell
227
-45
-17% -$7.75K 0.03% 100
2023
Q4 		$42.2K Buy
+272
New +$39.7K 0.03% 89

Other funds holding ABBV

Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
ATO
Alecta Tjanstepension Omsesidigt Stockholm, Sweden $23.8B AUM 34.25% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
HCM
Hamlin Capital Management New York $4.45B AUM 22.95% 1-Year Est. Return
AAMU
AEGON Asset Management (UK) Edinburgh, United Kingdom $9.38B AUM 48.94% 1-Year Est. Return
FWCM
Ferguson Wellman Capital Management Portland, Oregon $8.19B AUM 30.56% 1-Year Est. Return
AAIS
ABN AMRO Investment Solutions Paris Cedex 008 $11.5B AUM 32.2% 1-Year Est. Return

Clarity Asset Management's ABBV Position: Q2 2026 in Review

Clarity Asset Management sold out of AbbVie (ABBV) in Q2 2026, closing a stake of 145 shares — an estimated $31.6K sold.

Clarity Asset Management first reported a position in ABBV in Q4 2023 and held it in 10 quarters. The position peaked at $48.1K in Q3 2024. 1,519 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Clarity Asset Management reported no remaining AbbVie position as of Q2 2026 after selling out during the quarter.
  • Clarity Asset Management sold 145 AbbVie shares in Q2 2026, an estimated $31.6K.
  • Clarity Asset Management first reported a position in AbbVie in Q4 2023 and held it in 10 quarters.
  • Clarity Asset Management's AbbVie position peaked at $48.1K in Q3 2024.
  • 1,519 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Clarity Asset Management's 13F filing for Q2 2026, filed 16 Jul 2026.